Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis.
Cainap C, Ungur RA, Bochis OV, Achimas P, Vlad C, Havasi A, Vidrean A, Farcas A, Tat T, Gherman A, Piciu A, Bota M, Constantin AM, Pop LA, Maniu D, Crisan O, Cioban CV, Balacescu O, Coza O, Balacescu L, Marta MM, Dronca E, Cainap S.
Cainap C, et al. Among authors: bota m.
PLoS One. 2021 Apr 28;16(4):e0248922. doi: 10.1371/journal.pone.0248922. eCollection 2021.
PLoS One. 2021.
PMID: 33909622
Free PMC article.